Lewis-Lung (LL/2) - Syngeneic

 

Rincon Bio performs LL/2 syngeneic models to test efficacy of immunotherapies.  Please see below for additional information or to request a quote. 

Lung

Organism: Mus musculus, mouse  /  Tissue: lung  /  Disease: Lewis lung carcinoma

Notes

This line is widely used as a model for metastasis and is useful for studying the mechanisms of cancer chemotherapeutic agents. cell line established from the lung of a C57BL mouse bearing a tumor resulting from an implantation of primary Lewis lung carcinoma. Ref

in vivo

Used as a syngeneic model.  Implanted tumor cells create a model in which to test the efficacy of novel immunotherapies 

Request Quote

Receive a quote within one business day for a LL/2 syngeneic study

Rincon Bio Growth Curve

LLC.jpg

WHY WORK WITH

RINCON BIO?

DOMESTIC QUALITY at COMPETITIVE PRICES

 

When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

SPEED TO INITIATION
 

Most efficacy studies can be initiated within two business days.

PERSONAL TOUCH

 

We love our clients.  We are easy to work with.  And we develop a personal interest in our clients and their studies.